142 related articles for article (PubMed ID: 32978901)
21. Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
Liu B; Li L; Wang M; Wei L; Li J; Zou W; Lv Y; Zhang H; Liu S
Gynecol Oncol; 2019 Sep; 154(3):583-589. PubMed ID: 31307665
[TBL] [Abstract][Full Text] [Related]
22. Operation for locally advanced cervical cancer after concurrent chemoradiotherapy.
Ge J; Sun J; Li J; Zhang Q; Lv X; Chen B
Int J Clin Oncol; 2020 May; 25(5):948-954. PubMed ID: 32236755
[TBL] [Abstract][Full Text] [Related]
23. Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study.
Atci MM; Akagunduz B; Demir M; Dönmez Yilmaz B; Akin Telli T; Can O; Cil I; Goktas Aydın S; Ozyurt N; Onder AH; Selvi O; Sakin A
Oncol Res Treat; 2022; 45(5):254-261. PubMed ID: 35034017
[TBL] [Abstract][Full Text] [Related]
24. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.
Stenehjem DD; Bellows BK; Yager KM; Jones J; Kaldate R; Siebert U; Brixner DI
Oncologist; 2016 Feb; 21(2):196-204. PubMed ID: 26614710
[TBL] [Abstract][Full Text] [Related]
25. Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma.
Setakornnukul J; Thephamongkhol K
BMC Cancer; 2018 Mar; 18(1):329. PubMed ID: 29587665
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of adjuvant chemotherapy for locally advanced cervical cancer: A systematic review and meta-analysis.
Ma X; Fang J; Zhang L; Huang Y; Shen H; Ma X; Zhang S; Zhang B
Crit Rev Oncol Hematol; 2023 Apr; 184():103953. PubMed ID: 36889613
[TBL] [Abstract][Full Text] [Related]
27. Chemoradiotherapy with hyperthermia versus chemoradiotherapy alone in locally advanced cervical cancer: a systematic review and meta-analysis.
Yea JW; Park JW; Oh SA; Park J
Int J Hyperthermia; 2021; 38(1):1333-1340. PubMed ID: 34477028
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant and Adjuvant Treatments Compared to Concurrent Chemoradiotherapy for Patients With Locally Advanced Cervical Cancer: A Bayesian Network Meta-Analysis.
Qiao Y; Li H; Peng B
Front Oncol; 2022; 12():745522. PubMed ID: 35372073
[TBL] [Abstract][Full Text] [Related]
29. Cost-utility analysis of adjuvant trastuzumab therapy for HER2-positive early-stage breast cancer in the Philippines.
Genuino AJ; Chaikledkaew U; Guerrero AM; Reungwetwattana T; Thakkinstian A
BMC Health Serv Res; 2019 Nov; 19(1):874. PubMed ID: 31752849
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant chemotherapy versus concurrent chemoradiotherapy for high-risk cervical cancer after radical hysterectomy and systematic lymphadenectomy.
Takekuma M; Kasamatsu Y; Kado N; Kuji S; Tanaka A; Takahashi N; Abe M; Hirashima Y
Int J Clin Oncol; 2016 Aug; 21(4):741-747. PubMed ID: 26857458
[TBL] [Abstract][Full Text] [Related]
31. Cost-Utility Analysis of First-Line Pemetrexed Plus Cisplatin in Non-Small Cell Lung Cancer in Thailand.
Permsuwan U; Thongprasert S; Sirichanchuen B
Value Health Reg Issues; 2020 May; 21():9-16. PubMed ID: 31634796
[TBL] [Abstract][Full Text] [Related]
32. Economic evaluation of first-line adjuvant chemotherapies for resectable gastric cancer patients in China.
Tan C; Peng L; Zeng X; Li J; Wan X; Chen G; Yi L; Luo X; Zhao Z
PLoS One; 2013; 8(12):e83396. PubMed ID: 24340099
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
Phisalprapa P; Supakankunti S; Chaiyakunapruk N
J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
[No Abstract] [Full Text] [Related]
34. Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
She L; Tian K; Han J; Zuo W; Wang Z; Zhang N
Front Oncol; 2022; 12():904372. PubMed ID: 36176384
[TBL] [Abstract][Full Text] [Related]
35. Chemoradiotherapy treatment with gemcitabine improves renal function in locally advanced cervical cancer patients with renal dysfunction.
Alarcón-Barrios S; Luvián-Morales J; Castro-Eguiluz D; Delgadillo-González M; Lezcano-Velázquez BO; Arango-Bravo EA; Flores-Cisneros L; Aguiar Rosas S; Cetina-Pérez L
Curr Probl Cancer; 2024 Feb; 48():101041. PubMed ID: 37988902
[TBL] [Abstract][Full Text] [Related]
36. Cost-effectiveness of alternative treatments for depression in low-income women.
Beil H; Beeber LS; Schwartz TA; Lewis G
J Ment Health Policy Econ; 2013 Jun; 16(2):55-65. PubMed ID: 23999203
[TBL] [Abstract][Full Text] [Related]
37. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
[TBL] [Abstract][Full Text] [Related]
38. Cost-utility analysis of the newly recommended adjuvant chemotherapy for resectable gastric cancer patients in the 2011 Chinese National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology: Gastric Cancer.
Chongqing T; Liubao P; Xiaohui Z; Jianhe L; Xiaomin W; Gannong C; Siying W; Lihui O; Ziying Z
Pharmacoeconomics; 2014 Mar; 32(3):235-43. PubMed ID: 23709451
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study.
Kagabu M; Nagasawa T; Tatsuki S; Fukagawa Y; Tomabechi H; Takatori E; Kaido Y; Shoji T; Baba T
Medicina (Kaunas); 2021 May; 57(6):. PubMed ID: 34072478
[No Abstract] [Full Text] [Related]
40. Chemoradiotherapy followed by consolidation chemotherapy involving paclitaxel and carboplatin and in FIGO stage IIIB/IVA cervical cancer patients.
Mabuchi S; Isohashi F; Okazawa M; Kitada F; Maruoka S; Ogawa K; Kimura T
J Gynecol Oncol; 2017 Jan; 28(1):e15. PubMed ID: 27958682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]